(Q37801834)

23 August 2017

title

New vitamin D analogs and changing therapeutic paradigms (English)

1 reference

23 August 2017

0 references

0 references

John Cunningham

1

1 reference

23 August 2017

Daniel Zehnder

series ordinal

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

20 October 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

79

1 reference

23 August 2017

issue

7

1 reference

23 August 2017

page(s)

702-707

1 reference

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Meta-analysis: vitamin D compounds in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Mortality risk among hemodialysis patients receiving different vitamin D analogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Oral active vitamin D is associated with improved survival in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Mechanisms for the selective action of Vitamin D analogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Vitamin D and human health: lessons from vitamin D receptor null mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2010.387

1 reference

7 January 2021

Resurrection of vitamin D deficiency and rickets

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Transplantation: Supplemental vitamin D: will do no harm and might do good

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.387

7 January 2021

Identifiers

DOI

10.1038/KI.2010.387

1 reference

23 August 2017

1 reference